Health & Life Co., Ltd.
Health & Life Co., Ltd. manufactures and sells products for cardiovascular disease, in-vitro diagnostics, and respiratory care worldwide. It offers vibrating mesh nebulizers, blood pressure monitor products, IR thermometers, and hearing aid devices. The company was founded in 1996 and is based in New Taipei City, Taiwan.
Health & Life Co., Ltd. (1781) - Total Liabilities
Latest total liabilities as of September 2025: NT$326.71 Million TWD
Based on the latest financial reports, Health & Life Co., Ltd. (1781) has total liabilities worth NT$326.71 Million TWD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Health & Life Co., Ltd. - Total Liabilities Trend (2021–2024)
This chart illustrates how Health & Life Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Health & Life Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of Health & Life Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LMS Co. Ltd
KQ:073110
|
Korea | ₩81.93 Billion |
|
Voyageur Pharmaceuticals Ltd
PINK:VYYRF
|
USA | $2.23 Million |
|
Saga Pure ASA
OL:SAGA
|
Norway | Nkr4.22 Million |
|
Dish TV India Limited
PINK:DTTVY
|
USA | $57.40 Billion |
|
Delta Resources Ltd
PINK:DTARF
|
USA | $1.25 Million |
|
BeLive Holdings Ordinary Share
NASDAQ:BLIV
|
USA | $970.07K |
|
Medion AG
XETRA:MDN
|
Germany | €274.07 Million |
|
Malton Bhd
KLSE:6181
|
Malaysia | RM1.07 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down Health & Life Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.99 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Health & Life Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Health & Life Co., Ltd. (2021–2024)
The table below shows the annual total liabilities of Health & Life Co., Ltd. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$424.21 Million | +13.00% |
| 2023-12-31 | NT$375.42 Million | -12.12% |
| 2022-12-31 | NT$427.18 Million | +7.27% |
| 2021-12-31 | NT$398.22 Million | -- |